IL2 and neoplasm: We used a modified vaccinia virus in which the interleukin-2 gene was inserted into the thymidine kinase region of the virus and the construct was then injected directly into the tumor providing a source of interleukin-2 inside the tumor without viral replication in normal cells (Mukherjee et al., 2000).